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Report on EQUATOR Network launch meeting 26th June 2008 ‘‘Achieving
Transparency in Reporting Health Research’’‘‘Poor reporting cannot be seen as an isolated problem that can
be solved by targeting only one of the parties involved. A well-
coordinated effort, with collaboration between the research
and publishing communities, strongly supported by research
funders, will likely have a better chance of leading to improved
reporting of health research.’’1
Reporting quality of randomised controlled trials is a topic that
is taken seriously in the International Journal of Surgery. In 2007,
Riaz Agha and colleagues undertook a systematic review of the
reporting quality of randomised controlled trials in surgery.2 The
covering editorial3 queried who should take the responsibility for
generally educating all those involved so that they might achieve
a more conscientious approach to improving the quality of report-
ing. It is pleasing to be able to report that this responsibility has
been acknowledged, is being debated, and has been claimed,
steered by a group of people well experienced in these matters.
A new initiative, the EQUATOR Network, is directed by an interna-
tional Executive Group that brings together leading experts in
health research methodology, statistics, reporting and editorial
work (www.equator-network.org). It aims to improve the reliability
of scientiﬁc publications by promoting clarity, transparency and
accuracy in health research reporting. The Launch Meeting took
place on 26th June 2008 at the Royal Society of Medicine and was
attended by about 170 participants from a wide range of leading
organisations and institutions.
Sir Muir Gray, Director of the National Knowledge Service,
Oxford, recently given the role of Chief Knowledge Ofﬁcer for the
NHS, opened the meeting by sharing good news received only
that morning that the MRC (www.mrc.ac.uk/) had agreed to add
its ﬁnancial support to that already provided by the NHS Library
for Health (http://www.library.nhs.uk) and the National Institute
for Health Research (http://www.nihr.ac.uk/). He outlined the
beneﬁts of the growing trend towards digital publication. The IJS
has been a front-runner in recognising the beneﬁts of rapid
handling and online publication of accepted articles within days
of acceptance. The BMJ sees continuous publication as ‘the next
logical step’4: as from July 2008 all articles are published online
as they become ready prior to being selected for a subsequent print
issue.
Why should we all be concerned about achieving transparency
in reporting health research? Perhaps we should remember the
main goal: the relief of people’s illness and pain.5 The purpose of
undertaking research is to reduce uncertainties about treatments
and interventions so that clinicians and patients can decide1743-9191/$ – see front matter  2008 Surgical Associates Ltd. Published by Elsevier Lt
doi:10.1016/j.ijsu.2008.08.002together what is the best course of action to take. Doug Altman,
Director, Centre for Statistics in Medicine, University of Oxford,
presented summarised evidence that showed that many
published articles omit vital information: this demonstrates
a collective fault of authors, peer reviewers, and editors. Reporting
guidelines should help all these groups to ensure proper reporting
of research, which is an essential component of good research. If
authors of research reports fail to give a full description of the
treatment or intervention, doctors will not be able to help patients
as they should. Paul Glazsiou, Director, Centre for Evidence-based
Medicine, University of Oxford, UK, and GP, left us with no illusions
about the effects of inadequate reporting as it affected his ability
to advise and treat his patients. Not only will patients be short-
changed, but also without adequate descriptions, ‘‘tens of millions
of pounds of research effort could be wasted each year because
effective treatments cannot be implemented or will lack ﬁdelity
when applied’’.6 A further consequence of poor reporting of trials
is felt when compiling systematic reviews. As Ian Needleman,
Director, International Centre for Evidence-based Oral Health,
UCL, London, UK, explained, the totality of evidence in a critical
summary, as called for by Archie Cochrane, is only meaningful as
a concept if potentially contributing studies are reported in sufﬁ-
cient detail to allow evaluation and inclusion. In his view, because
of the potentially profound impact of poor reporting both on the
understanding of the totality of evidence and on the delivery of
health care, adequate reporting should be considered as an ethical
responsibility.
The next two sessions provided suggestions about what might
be done to improve the quality of research reports. John Hoey,
Queen’s University, Kingston, Canada, deﬁned the qualities of
good research reporting as accuracy, transparency, and efﬁcacy.
Having deﬁned these principles in detail he reminded us of the
published research evaluations of quality that are available:
CONSORT, STROBE, STARD, and others (see ‘reporting guidelines’
www.equator-network.org). David Moher, Director, Chalmers
Research Group, University of Ottawa, Canada, gave a brief histor-
ical perspective of the development and use of guidelines for health
research. He described how to develop a reporting guideline, and
their current use, uptake, endorsement, and adherencewithin jour-
nals. He concluded by considering the future optimal use of report-
ing guidelines for a wide variety of stakeholders. He drew attention
to the front page of The Independent of Wednesday, 25th June
2008, with its picture of a clipboard, and the headline: ‘A SURGICAL
REVOLUTION’ – a surgical safety checklist that could prevent thou-
sands of deaths.7d. All rights reserved.
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described how the EQUATOR Network acts as an umbrella organi-
zation bringing together not only guidance, but also all important
stakeholders that inﬂuence the quality of health research report-
ing: researchers, research funders; journal editors, peer reviewers
and publishers; reporting guideline developers; and other organi-
sations and individuals involved in the publication of health
research. She also described the major goals of EQUATOR which
include
 The development of an Internet-based resource centre.
 Assistance in the development, dissemination and implementa-
tion of reporting guidelines.
 Development of educational and training programmes relating
to the use of reporting guidelines.
 Assessment of journals’ implementation of reporting guidelines.
 Audit of reporting quality across health research literature.
A major problem is securing sufﬁcient funding for the develop-
ment, evaluation and dissemination of reporting guidelines, and
a lack of strategies to accomplish these essential activities. Iveta
also drew attention to the need to harmonise methods used in
the development of reporting guidelines.
Altruism is often the motive for patients to volunteer to partic-
ipate in trials. They do so in the expectation that their participation
will contribute to the sum of human knowledge. It follows that
there is a scientiﬁc, ethical and moral duty incumbent on those
involved in producing and publishing research reports to do it fully
and transparently. Davina Ghersi, Co-ordinator of the International
Clinical Trials Registry at WHO, Geneva, vividly upheld and illus-
trated this obligation.4 She called for the accountability from fun-
ders and ethics committees, who should ensure that research
proposals conform to the highest possible standards, ultimately
capable of producing full data that are usable, meaningful and
accessible. Funders should not enforce restrictions on reporting in
contracts or agreements.
Rapid access to research reports proves vital. Paul Ayris, Director
of Library Services at University College, London, and UCL Copyright
Ofﬁcer, contrasted the traditional model of, say, the BritishMuseum
Reading Room pulling people into its library space, with today’s
networked and global environment, where the library is just one
of the content providers. Researchers no longer have the need to
set foot in a library: the world is their oyster. He suggested that
academic libraries should therefore push8 stuff out to where the
user is. He cited Matthew Cockerill survey, submitted to the House
of Commons Science and Technology’s Committee Inquiry that
showed how few texts are currently accessible to the general
public:
‘‘Our results indicate that although the majority (90%) of the result-
ing research articles now exist in online full text form, less than
a third (30%) of the online full texts are accessible to the general
public immediately upon publication. Perhaps more surprisingly,
despite the NHS’s major recent program of electronic journal
procurement, only 40% of the online full texts of these NHS-funded
research articles are immediately accessible to NHS staff at the
hospital we studied. These preliminary results suggest that the
current system of scientiﬁc publishing is failing to make NHS
research fully accessible to those who could beneﬁt from it,
including staff within the NHS.’’9
An important role for publishers is to ensure reliability of scien-
tiﬁc publications. Chris Graf, Publisher, International Journal of Clin-
ical Practice, Wiley–Blackwell Publishing, Oxford, UK, jolted
delegates with details from the report of a survey undertaken by
the Ofﬁce of Research Integrity10 showing just how prevalent
research misconduct is. The report suggests that many researchmisconduct incidents in the United States go unreported. Most
editors surveyed were not very concerned about publication ethics:
they thought problems were rare. They were also unaware of good
publication ethics guidelines, indicating just howmuch work there
is for publishers to do. The authors of the report concluded that
‘‘falsiﬁed and fabricated research records, publications, disserta-
tions and grant applications are much more prevalent than has
been suspected to date.’’ Help is at hand. COPE (http://www.publi-
cationethics.org.uk/) is a forum for editors of peer-reviewed jour-
nals to discuss issues related to the integrity of the scientiﬁc
record; it supports and encourages editors to report, catalogue
and instigate investigations into ethical problems in the publication
process. Formed in 1997, the Committee on Publication Ethics’
(COPE) major objective is to provide a sounding board for editors
who were struggling with how best to deal with possible breaches
in research and publication ethics. There is also a co-operative
publisher service – CROSS CHECK (http://www.crossref.org/
01company/pr/press061908.htm) – a plagiarism detection service
that was launched on 19th June 2008 by Elsevier. It provides a reli-
able way to verify the originality of scholarly content in work
submitted for publication. Best Practice Guidelines on Publication
Ethics, promoting research integrity and responsible publication
practices, are for everyone engaged in the publication process:
editors, authors, manuscript reviewer and referees.
Trish Groves, Deputy Editor, BMJ, London, UK, described
EQUATOR as a ‘huge leap forward’ making it easier to get reporting
guidelines into practice. She saw provision of training as an impor-
tant step. However, she emphasized that it was not necessarily
about ‘ticking all the boxes’. She suggested that perhaps EQUATOR
could have ﬂowcharts like COPE and ‘how to’ sections for editors,
reviewers and authors. She encouraged EQUATOR to do more to
market their guidelines to authors and editors, focusing on the
aims and beneﬁts. A balance should be struck between relevance
and detail. The purpose of guidelines should be made clear: i.e. to
provide guidance on reporting research transparently and fully so
that readers (clinicians, learners, educators, other researchers, pol-
icymakers, patients) can understand what the investigators did and
judge its quality, and so that systematic reviewers can select
studies. She proposed her own ‘CLEAR’ statement: ‘Concise Lists
for Editors and Authors on Reporting’ before we went for TEA –
That’s Enough Acronyms!
1. First annual EQUATOR Annual Lecture: ‘‘Meeting the
research information needs of patients and clinicians more
effectively’’
Iain Chalmers, Editor, James Lind Library, Oxford, UK, www.ja-
meslindlibrary.org, began the 1st EQUATOR Annual Lecture by
clearly deﬁning the problem: people are suffering and dying unnec-
essarily because of insufﬁcient clinician and patient access to reli-
able, up-to-date information about completed and ongoing
research. He used his early experience as a clinician and his later
experience as a patient to describe why he has been obsessed for
the past 40 years with the need to meet the research information
needs of patients and clinicians more effectively.
He graphically described how, as a clinician in Palestine in 1969/
1970, he could have served his patients better if he had had more
humility, and if he had had access to systematic reviews of relevant
clinical trials. He described how, because he had been taught not to
administer antibiotics to children with measles, many lives were
lost through ignorance. Most of the children he was treating were
malnourished. But ﬁndings of a systematic review of clinical trials
reported between 1939 and 1967, unavailable to him in Palestine,
show that antibiotics prescribed for children with measles can
reduce their risk of developing pneumonia. In October 2006,
a paper about prophylactic use of antibiotics in measles published
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biotics had less pneumonia and conjunctivitis and had signiﬁcantly
higher weight gains in the month after inclusion. The results indi-
cate that prophylactic antibiotics have an important role to play in
the management of measles infection in low-income countries.’’
Precise details of the interventions and duration of use were
provided in this report, thus enabling doctors to prescribe
effectively.
As a patient, having experienced retained/impacted earwax12 –
a commonproblem causing impaired hearing and localised eczema,
sometimes associated with serious complications, and costing the
NHS £50million per year – Sir Iain discovered that the only system-
atic review available was of little help. The authors of the report
found that water and saline drops seemed to be as good as more
costly commercial products, but concluded that ‘‘the quality of
the research is generally low and more research is needed’’.13
He drew attention to the WHO International Clinical Trials
Registry Platform (ICCTR), the mission of which is ‘‘to ensure that
a complete view of research is accessible to all those involved in
health care decision making’’ with the purpose of improving
research transparency, ultimately strengthening the validity and
value of the scientiﬁc evidence base. The WHO believes that ‘‘the
registration of all interventional trials is a scientiﬁc, ethical and moral
responsibility’’ (http://www.who.int/ictrp/en/). Additionally, to
improve reports of research, compliance is required from many
leading journals to guidelines already available.
As long ago as 1950, Marc Daniels14 drew attention to the fact
that essential details are omitted from reports. He was a member
of the team that included Philip D’Arcy Hunt and Austin Bradford
Hill who were responsible for designing, co-ordinating and report-
ing the MRC trial of streptomycin for pulmonary tuberculosis in
1947/1948 (see: www.jameslindlibrary.org/trial_records/20th_
Century/1950s/daniels/daniels_biog.html).
2. The importance of systematic reviews
Fifteen years ago, a paper in the Lancet taught that ‘‘good
systematic reviews provide a valuable foundation for new research
initiatives’’.15 Yet the proportion of study investigations using
systematic reviews is still very limited, resulting in trials being con-
ducted long after adequate evidence was available, as was the case
with the use of aprotinin in cardiac surgery.16 Such failure to
prepare and refer to systematic reviews results in harm and wasted
resources in health care and health research. Sir Iain emphasized
that discussion section of reports should begin and end with up-
to-date systematic reviews of other relevant evidence.17
He traced how, following his salutary experience in Gaza in
1969/1970, he had become involved in improving the syntheses
of research ﬁndings (systematic reviews), ﬁrstly through the elec-
tronic dissemination and maintenance of systematic reviews of
controlled trials in perinatal care, from 1988 with the Oxford Data-
base of Perinatal Trials (ODPT); then from 1993 to1995 with
Cochrane Pregnancy and Childbirth Database (CPCD); following in
1995 with the Cochrane Database of Systematic Reviews (CDSR).
His conviction that underreporting of research (which amounts to
scientiﬁc misconduct)18 by failing to provide adequate, publicly
available reports of the results of clinical trials does injustice to
the patients who have participated in them, and about the dangers
of publication bias, have driven him towork to improvematters. He
expressed his belief that EQUATOR should help to improve the
quality and relevance of research. He spoke of his current work
with the James Lind Alliance – ‘tackling treatment uncertainties
together’ (www.lindalliance.org) – improving the relevance of
research to patients and clinicians. Currently, it is looking speciﬁ-
cally at determining research priorities in asthma, bringing
together Asthma UK (an organization representing people withasthma in the UK – www.asthma.org.uk/) and the British Thoracic
Society (representing health professionals with an interest in respi-
ratory disease – www.brit-thoracic.org.uk), to
 ﬁnd out which unanswered questions are of importance to
patients, carers and clinicians
 ﬁnd out which outcomes are important to patients
 make uncertainties explicit (throughDUETs –Database ofUncer-
tainties about the Effects of Treatment (www.duets.nhs.uk)
 do research to address uncertainties
He quoted from the General Medical Council’s guidance for
doctors, published on 13th November 2006, in particular, para 14:
‘‘You must work with colleagues and patients to maintain and
improve the quality of your work and promote patients safety. In
particular you must:
(f) help to resolve uncertainties about the effects of treatments.’’
As an example, he drew attention to the terrible, enduring
consequences caused by failure to address uncertainty over 30
years about whether to use caffeine in newborn infants to reduce
apnoeic episodes. The results of a trial published in 2007 showed
that ‘‘caffeine therapy for apnea of prematurity improves the rate of
survival without neurodevelopmental disability at 18–21 months in
infants with very low birthweight.’’19 Sir Iain went on to describe
the report of the CRASH trial as an exemplar of what is needed.20
It was exemplary because:
 It refers to the current uncertainty about the effects of a treat-
ment, manifested in a systematic review of all the existing
evidence, and in variations in clinical practice.
 It notes that the trial was registered and the protocol pub-
lished prospectively.
 It sets out the new results in the context of an updated system-
atic review of all of the existing evidence.
 It provides readers with all the evidence needed for action to
prevent thousand of iatrogenic deaths.
Sir Iain concluded by drawing attention to various ways of
exploiting the possibilities offered by electronic publishing that
have been proposed. For example, the review and electronic publi-
cation of research protocols, and electronic publication and
archiving of medical research.21–23 He emphasized that he believes
it is a shared responsibility to meet the research information needs
of patients and clinicians more effectively. He said that it is encour-
aging that an improvement to the evidence base has been promised
in Lord Darzi’s Interim Report, in which he expressed his wish to
‘‘shape the NHS for the 21st Century’’ with the creation of
a ‘‘national clinical evidence base available to commissioners, prac-
titioners, patients and public alike’’.24
‘‘Teach thy tongue to say I do not know and thou shalt prog-
ress’’ Maimonides, Spanish philosopher 1135–1204
Slides used by presenters at the meeting are available on the
EQUATOR meeting website (http://www.equator-network.org/
?o¼1125).
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